Vaxcyte Inc (PCVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -604,924 | -320,622 | -766,628 | -520,121 | -307,291 |
| Depreciation Amortization | 7,486 | 2,742 | 10,426 | 3,390 | 457 |
| Accounts payable and accrued liabilities | 31,285 | -269 | 19,906 | -1,761 | -19,638 |
| Other Working Capital | -2,237 | -2,910 | -3,452 | 16,251 | -15,824 |
| Other Operating Activity | 55,294 | 40,434 | 84,171 | 71,496 | 54,856 |
| Operating Cash Flow | $-513,096 | $-280,625 | $-655,577 | $-430,745 | $-287,440 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -852,806 | -584,129 | -1,211,499 | -918,850 | -663,535 |
| PPE Investments | -6,426 | -2,107 | -13,713 | -11,059 | -7,235 |
| Sale Of Investment | 786,483 | 365,513 | 1,705,826 | 1,289,631 | 901,100 |
| Other Investing Activity | -12,942 | -12,687 | -43,260 | -37,493 | -29,271 |
| Investing Cash Flow | $-85,691 | $-233,410 | $437,354 | $322,229 | $201,059 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 618,639 | 610,878 | N/A | 9,590 | 9,284 |
| Other Financing Activity | -11,355 | -9,295 | 2,014 | -9,984 | -6,007 |
| Financing Cash Flow | $607,284 | $601,583 | $2,014 | $-394 | $3,277 |
| Exchange Rate Effect | 733 | -664 | 2,439 | 2,263 | 1,972 |
| Beginning Cash Position | 175,425 | 175,425 | 389,195 | 389,195 | 389,195 |
| End Cash Position | 184,655 | 262,309 | 175,425 | 282,548 | 308,063 |
| Net Cash Flow | $9,230 | $86,884 | $-213,770 | $-106,647 | $-81,132 |
| Free Cash Flow | |||||
| Operating Cash Flow | -513,096 | -280,625 | -655,577 | -430,745 | -287,440 |
| Capital Expenditure | -6,426 | -2,107 | -13,713 | -11,059 | -7,235 |
| Free Cash Flow | -519,522 | -282,732 | -669,290 | -441,804 | -294,675 |